Skip to main content
. 2020 May 8;10:7826. doi: 10.1038/s41598-020-64832-5

Figure 3.

Figure 3

Levels of COX2 and pERK expression in cUC tissue. (A) Representative image of the COX2 expression in normal urothelium (top left) and blood vessel (top right) as negative and positive control, respectively, and cUC tissues (middle and bottom) at 100-fold magnification. Immunohistochemical score (IHS) was determined by a semi-quantitative method as described in Materials and Methods. IHSs of presented pictures were 12 (middle left), 9 (middle right), 6 (bottom left), 2 (bottom right), respectively. Scale bar: 200 μm. (B) A summarising box plot for COX2 expression in BRAF wild-type (WT; blue) and mutant cUC tissue (Mutant; red). Y axis represents IHS. p = 0.0569 (Wilcoxon rank sum test). (C) Representative image of the pERK expression in normal urothelium (top left) and blood vessel (top right) as negative and positive control, respectively, and cUC tissues (middle and bottom) at 200-fold magnification. IHSs of presented pictures were 12 (middle left), 9 (middle right), 4 (bottom left), 0 (bottom right), respectively. Scale bar: 100 μm. (D) A summarising box plot for COX2 expression in BRAF wild-type (WT; blue) and mutant cUC tissue (Mutant; red). Y axis represents IHS. *Indicates p < 0.05 (Wilcoxon rank sum test). (E) A summarising box plot for COX2 expression in cUC tissues which showed weak pERK expression with IHS < 6 (pERK_low; grey) and strong pERK expression with IHS ≥ 6 (pERK_high; orange). Y axis represents IHS for COX2. *Indicates p < 0.05 (Wilcoxon rank sum test).